Trying to separate three different claims about alpha-GPC: that it is the right molecule, that it is the right dose, and that it does something useful.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
If you need three other compounds to notice the first one, you have not tested the first one.
How do you separate the compound effect from the routine around it?
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison. Not on alpha-GPC but the pattern is familiar.
Same here.
Same for me with alpha-GPC, unfortunately.
What is the first thing you would read if you were starting from zero? Same for me with alpha-GPC, unfortunately.